Evidence map›Paper›PMID 29884836›Full record

ArticleNature communications2018

Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exit.

Kerstin Schott, Nina V Fuchs, Rita Derua, Bijan Mahboubi, Esther Schnellbächer, Janna Seifried, Christiane Tondera, Heike Schmitz, Caitlin Shepard, Alberto Brandariz-Nuñez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Macrophage Cell Cycle.Results and problems in cell differentiation · 2024
    Review
  12. The Role of p53 in HIV Infection.Current HIV/AIDS reports · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Kerstin SchottHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Nina V FuchsHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Rita DeruaDepartment of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, 3000, Leuven, Belgium.
Bijan MahboubiCenter for Drug Discovery, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA.
Esther SchnellbächerHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Janna SeifriedHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Christiane TonderaHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Heike SchmitzHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Caitlin ShepardCenter for Drug Discovery, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA.
Alberto Brandariz-NuñezDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.ORCID http://orcid.org/0000-0002-0640-1599
Felipe Diaz-GrifferoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Andreas ReuterDivision of Allergology, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Baek KimCenter for Drug Discovery, Department of Pediatrics, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA.
Veerle JanssensDepartment of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, 3000, Leuven, Belgium.ORCID http://orcid.org/0000-0002-6772-8448
Renate KönigHost-Pathogen Interactions, Paul-Ehrlich-Institut, 63225, Langen, Germany. Renate.Koenig@pei.de.
Paul Ehrlich Institut · DEEmory University · USAlbert Einstein College of Medicine · USKU Leuven · BESanford Burnham Prebys Medical Discovery Institute · USVIB-KU Leuven Center for Microbiology · BE

Funding

Lentivirus Replication Strategy and PathogenesisR01AI136581 · NIAID · EMORY UNIVERSITY · PI Baek Kim · 2018 to 2026
$3.9M
SAMHD1 controls dNTP pool and HIV sensitivity to NRTIsR01GM104198 · NIGMS · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2012 to 2018
$2.3M
Regulation of SAMHD1 antiviral activityR01GM123540 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DIAZ-GRIFFERO, FELIPE · 2016 to 2018
$1.4M
NIAID NIH HHS R01 AI136581NIGMS NIH HHS R01 GM104198NIGMS NIH HHS R01 GM123540
6 · The paper itself

Abstract

SAMHD1 is a critical restriction factor for HIV-1 in non-cycling cells and its antiviral activity is regulated by T592 phosphorylation. Here, we show that SAMHD1 dephosphorylation at T592 is controlled during the cell cycle, occurring during M/G

Indexed as

MitosisAnimalsCD4-Positive T-LymphocytesCells, CulturedHEK293 CellsHeLa CellsHIV-1HoloenzymesHost-Pathogen InteractionsHumansMacrophagesPhosphorylationProtein BindingProtein Phosphatase 2RNA InterferenceSAM Domain and HD Domain-Containing Protein 1HoloenzymesPPP2R2A protein, humanProtein Phosphatase 2SAM Domain and HD Domain-Containing Protein 1

Identifiers

PMID29884836
PMCPMC5993806
OpenAlexW2806418750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.